Together, these data in anxiety models suggest that SSR411298 may be preferentially active under conditions of high stress, a finding that adds further strength to an already substantive body of evidence that genetic deletion or pharmacological blockade of FAAH produced anxiolytic-like effects more reliably under conditions of high environmental aversiveness (for a recent review, see12). This evidence concerns the gene FAAH and Anxiety.